B
Das A, Vishvakarma V, Dey A, Dey S, Gupta A, Das M, Vishwakarma KKant, Roy DSaha, Yadav S, Kesarwani S, Venkatramani R, Maiti S.
2021. Biophysical properties of the isolated spike protein binding helix of human ACE2.. Biophys J. 120(14):2785-2792. DOI:10.1016/j.bpj.2021.06.017.
E
N
Bhatt T, Dam B, Khedkar SUday, Lall S, Pandey S, Kataria S, Ajnabi J, Gulzar S-E-J, Dias PM, Waskar M, Raut J, Sundaramurthy V, Vemula PKumar, Ghatlia N, Majumdar A, Jamora C.
2023. Niacinamide enhances cathelicidin mediated SARS-CoV-2 membrane disruption.. Front Immunol. 14:1255478. DOI:10.3389/fimmu.2023.1255478.
S
Mlcochova P, Kemp SA, Dhar MShanker, Papa G, Meng B, Ferreira IATM, Datir R, Collier DA, Albecka A, Singh S, Pandey R, Brown J, Zhou J, Goonawardane N, Mishra S, Whittaker C, Mellan T, Marwal R, Datta M, Sengupta S et al..
2021. SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion.. Nature. 599(7883):114-119. DOI:10.1038/s41586-021-03944-y.
Prabhakara C, Godbole R, Sil P, Jahnavi S, Gulzar S-E-J, van Zanten TS, Sheth D, Subhash N, Chandra A, Shivaraj A, Panikulam P, U I, Nuthakki VKumar, Puthiyapurayil TParassini, Ahmed R, Najar AHussain, Lingamallu SManoz, Das S, Mahajan B, Vemula P et al..
2021. Strategies to target SARS-CoV-2 entry and infection using dual mechanisms of inhibition by acidification inhibitors.. PLoS Pathog. 17(7):e1009706. DOI:10.1371/journal.ppat.1009706.